🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Investigational Treatment Acquiring Traction Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with numerous of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers market the substance there before directing customers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

However, doctors and pharmacists have cautions that the sale of what is still an unlicensed medication in the UK is worrisome and could lead to users injecting products of uncertain source.

Several professionals said the popularity for the experimental drug could be linked to the rising price of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the British medical regulations.

Some content creators try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, advertising, and customer laws, risking penalties, legal action or imprisonment.

Platform Response and Material Removal

According to TikTok, the platform has removed problematic material and banned related hashtags and query recommendations. The organization stated it was dedicated to keeping the service safe and allocating resources in strengthening compliance measures.

Online Trading Activities

Research also found communities with up to nine thousand members marketing the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up groups with thousands of members, filled with photos of weight loss, positive reviews and step-by-step guides for preparing or injecting at residence.

After moments of joining one community, a seller posted contact information, where most transactions occur. The seller sent an instruction manual and promised shipping within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.

Item Information and Pricing

Within these groups, posts display black plastic packages with postal service labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled pens usually sold at £160 for 20mg. When questioned how long a injector should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram said it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering substances they cannot confirm. Even if the science behind retatrutide is valid, these digital versions may not contain what they advertise,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in interest to current cost increases for authorized slimming medications such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has previously encountered individuals harmed by self-injection from unverified suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly investigational product not yet approved … may subject patients to possibly serious medical dangers”.